In commenting on the study, Dr. Kevin K. Tremper, Chairman of Anesthesia at University of Michigan said, "One of the biggest challenges we have in the operating room is determining whether, from a fluid volume perspective, a patient is full or empty. If PVI can help us noninvasively determine this in real time, PVI will be a huge benefit to clinicians and positively impact patient care and safety."
Built on the "gold-standard" of Masimo SET Read-Through Motion and Low Perfusion technology, Masimo Rainbow SET is the first and only upgradeable technology platform capable of continuously and noninvasively measuring carboxyhemoglobin (SpCO) and methemoglobin (SpMet), in addition to oxyhemoglobin (SpO2), perfusion index (PI), Pleth Variability Index (PVI) and pulse rate.
Masimo (Nasdaq: MASI) develops innovative monitoring technologies that
significantly improve patient care-helping solve "unsolvable" problems. In
1995, the company debuted Read-Through Motion and Low Perfusion pulse
oximetry, known as Masimo SET, and with it virtually eliminated false
alarms and increased pulse oximetry's ability to detect life-threatening
events. More than 100 independent and objective studies have confirmed that
Masimo SET technology allows clinicians to accurately monitor blood oxygen
saturation in critical care situations. Our Masimo SET platform has
significantly addressed many of the previous technology limitations, has
substantially contributed to improved patient outcomes and has been
referred to by several industry sources as the gold standard in pulse
oximetry. In 2005, Masimo introduced Masimo Ra
Copyright©2007 PR Newswire.
All rights reserved